Monthly Archives: October 2021

Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19

SARS-CoV-2 infection is associated with altered gut microbiota composition. Phylogenetic groups of gut bacteria involved in the metabolism of short chain fatty acids were depleted in SARS-CoV-2-infected patients. We aimed to characterize functional pro… Continue reading

Posted in News | Comments Off on Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19

Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk

Eosinophilic esophagitis (EoE) can progress to fibrostenosis by unclear mechanisms. Herein, we investigated gene dysregulation in fibrostenotic EoE, its association with clinical parameters and specific pathways, and the functional consequences. Continue reading

Posted in News | Comments Off on Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk

Comparing colorectal cancer screening outcomes in the International Cancer Screening Network (ICSN): A Consortium proposal

Posted in News | Comments Off on Comparing colorectal cancer screening outcomes in the International Cancer Screening Network (ICSN): A Consortium proposal

Connecting the dots: Dietary fat, microbiota dysbiosis, altered metabolome and colon cancer

Posted in News | Comments Off on Connecting the dots: Dietary fat, microbiota dysbiosis, altered metabolome and colon cancer

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021

Gastrointestinal diseases account for considerable health care use and expenditures. We estimated the annual burden, costs, and research funding associated with gastrointestinal, liver, and pancreatic diseases in the United States. Continue reading

Posted in News | Comments Off on Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021

New role for fatty acid receptor regulation of immune cells to control intestinal inflammation

Posted in News | Comments Off on New role for fatty acid receptor regulation of immune cells to control intestinal inflammation

Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals

To successfully implement imaging-based pancreatic cancer (PC) surveillance, it is key to understand the timeline and morphological features of neoplastic progression. We aimed to investigate the progression to neoplasia from serial prediagnostic pancr… Continue reading

Posted in News | Comments Off on Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals

Clinical Management of Pancreatic Premalignant Lesions

Posted in News | Comments Off on Clinical Management of Pancreatic Premalignant Lesions

MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs

Hepatocellular carcinoma (HCC) is characterized by intratumoral accumulation of regulatory T-cells (Tregs), which suppresses antitumor immunity. This study was designed to investigate how microRNAs regulate immunosuppression in HCC. Continue reading

Posted in News | Comments Off on MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs

STRAP: a Bridge between Mutant APC and Wnt/ß-Catenin Signaling in Intestinal Cancer

Posted in News | Comments Off on STRAP: a Bridge between Mutant APC and Wnt/ß-Catenin Signaling in Intestinal Cancer